ペプチドリームの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/01/06 | 5,600 | 5,740 | 5,520 | 5,710 | -20 | -0.3% | 541,000 |
2021/01/05 | 5,470 | 5,880 | 5,460 | 5,730 | +490 | +9.4% | 1,406,700 |
2021/01/04 | 5,270 | 5,280 | 5,180 | 5,240 | ±0 | ±0% | 224,200 |
2020/12/30 | 5,260 | 5,280 | 5,190 | 5,240 | -80 | -1.5% | 263,800 |
2020/12/29 | 5,250 | 5,320 | 5,190 | 5,320 | +50 | +0.9% | 307,700 |
2020/12/28 | 5,340 | 5,370 | 5,240 | 5,270 | -40 | -0.8% | 280,900 |
2020/12/25 | 5,410 | 5,410 | 5,290 | 5,310 | -100 | -1.8% | 176,300 |
2020/12/24 | 5,390 | 5,410 | 5,310 | 5,410 | +50 | +0.9% | 251,200 |
2020/12/23 | 5,310 | 5,380 | 5,290 | 5,360 | +60 | +1.1% | 362,400 |
2020/12/22 | 5,380 | 5,400 | 5,270 | 5,300 | -60 | -1.1% | 315,400 |
2020/12/21 | 5,430 | 5,450 | 5,340 | 5,360 | -60 | -1.1% | 335,000 |
2020/12/18 | 5,430 | 5,470 | 5,330 | 5,420 | +90 | +1.7% | 545,400 |
2020/12/17 | 5,300 | 5,360 | 5,260 | 5,330 | ±0 | ±0% | 367,400 |
2020/12/16 | 5,480 | 5,490 | 5,330 | 5,330 | -100 | -1.8% | 407,700 |
2020/12/15 | 5,480 | 5,510 | 5,420 | 5,430 | +40 | +0.7% | 459,000 |
2020/12/14 | 5,490 | 5,510 | 5,390 | 5,390 | -120 | -2.2% | 316,300 |
2020/12/11 | 5,430 | 5,530 | 5,420 | 5,510 | +80 | +1.5% | 384,600 |
2020/12/10 | 5,250 | 5,430 | 5,220 | 5,430 | +110 | +2.1% | 402,100 |
2020/12/09 | 5,290 | 5,340 | 5,230 | 5,320 | +110 | +2.1% | 302,600 |
2020/12/08 | 5,250 | 5,250 | 5,150 | 5,210 | -110 | -2.1% | 402,300 |
2020/12/07 | 5,420 | 5,450 | 5,270 | 5,320 | -100 | -1.8% | 389,500 |
2020/12/04 | 5,520 | 5,540 | 5,370 | 5,420 | -130 | -2.3% | 379,500 |
2020/12/03 | 5,420 | 5,620 | 5,420 | 5,550 | +110 | +2% | 506,700 |
2020/12/02 | 5,400 | 5,530 | 5,370 | 5,440 | -50 | -0.9% | 625,400 |
2020/12/01 | 5,290 | 5,520 | 5,280 | 5,490 | +170 | +3.2% | 961,400 |
2020/11/30 | 5,180 | 5,330 | 5,160 | 5,320 | +140 | +2.7% | 1,124,500 |
2020/11/27 | 5,020 | 5,180 | 5,010 | 5,180 | +160 | +3.2% | 1,452,500 |
2020/11/26 | 4,985 | 5,060 | 4,935 | 5,020 | +10 | +0.2% | 382,300 |
2020/11/25 | 4,970 | 5,090 | 4,940 | 5,010 | +160 | +3.3% | 768,800 |
2020/11/24 | 4,905 | 4,935 | 4,800 | 4,850 | +50 | +1% | 532,400 |
2020/11/20 | 4,705 | 4,800 | 4,675 | 4,800 | +5 | +0.1% | 419,500 |
2020/11/19 | 4,800 | 4,810 | 4,680 | 4,795 | -10 | -0.2% | 595,100 |
2020/11/18 | 4,775 | 4,885 | 4,760 | 4,805 | +30 | +0.6% | 484,400 |
2020/11/17 | 5,060 | 5,070 | 4,740 | 4,775 | -325 | -6.4% | 822,200 |
2020/11/16 | 5,220 | 5,240 | 5,090 | 5,100 | -80 | -1.5% | 396,200 |
2020/11/13 | 5,140 | 5,220 | 5,060 | 5,180 | +40 | +0.8% | 547,300 |
2020/11/12 | 5,140 | 5,200 | 5,100 | 5,140 | +20 | +0.4% | 381,200 |
2020/11/11 | 5,090 | 5,160 | 5,060 | 5,120 | +80 | +1.6% | 443,300 |
2020/11/10 | 5,070 | 5,140 | 5,000 | 5,040 | -40 | -0.8% | 493,100 |
2020/11/09 | 5,080 | 5,100 | 5,010 | 5,080 | +60 | +1.2% | 342,400 |
2020/11/06 | 5,100 | 5,150 | 5,000 | 5,020 | -70 | -1.4% | 525,300 |
2020/11/05 | 5,000 | 5,100 | 4,980 | 5,090 | +120 | +2.4% | 479,400 |
2020/11/04 | 4,970 | 4,995 | 4,885 | 4,970 | +60 | +1.2% | 555,200 |
2020/11/02 | 4,850 | 4,925 | 4,835 | 4,910 | +85 | +1.8% | 363,500 |
2020/10/30 | 4,875 | 4,905 | 4,820 | 4,825 | -80 | -1.6% | 394,700 |
2020/10/29 | 4,780 | 4,905 | 4,780 | 4,905 | +85 | +1.8% | 301,300 |
2020/10/28 | 4,800 | 4,855 | 4,765 | 4,820 | +20 | +0.4% | 253,400 |
2020/10/27 | 4,740 | 4,820 | 4,685 | 4,800 | +45 | +0.9% | 256,800 |
2020/10/26 | 4,840 | 4,910 | 4,755 | 4,755 | -100 | -2.1% | 395,800 |
2020/10/23 | 4,765 | 4,860 | 4,730 | 4,855 | +20 | +0.4% | 355,500 |
1051~
1100
件表示中 / 2900件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ペプチド | 187,700円 | +5.0% | +1.5% | 0.00% | 16.11倍 | 4.29倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 360,000円 | +7.9% | +8.9% | 3.44% | 7.70倍 | 1.03倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
住友ファーマ | 61,900円 | +21.1% | - | 0.00% | 15.37倍 | 2.15倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
科研薬 | 414,000円 | +30.5% | +111.0% | 4.59% | 11.67倍 | 1.02倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 383,500円 | +14.5% | -2.3% | 2.35% | 14.03倍 | 0.75倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム